Article
Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation - 1 Apr 2018
William Basem M, Wang Tao, Haagenson Michael D, Fleischhauer Katharina, Verneris Michael, Hsu Katharine C, de Lima Marcos J, Fernandez-Viña Marcelo, Spellman Stephen R, Lee Stephanie J, Hill Brian T
Abstract excerpt
Even in the modern era of targeted therapies, allogeneic hematopoietic stem cell transplantation (allo-HCT) can offer a chance of extended survival in B cell non-Hodgkin lymphoma (B-NHL) patients who relapse after or are deemed ineligible for autologous transplantation. A better understanding of the factors influencing the graft-versus-lymphoma (GVL) response would be useful in identifying B-NHL patients who may...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.